FDA Gene Therapy Office Chief Prefers Flexibility With Accelerated Approval Confirmatory Trials
Executive Summary
Ideally, the studies would be underway at the time of approval, as the US FDA’s new authority allows, but Office of Therapeutic Products Director Nicole Verdun sys there will be exceptions.